Company Filing History:
1 out of 16 
1 out of 527 
1 out of 2 Years Active: 2017-2022
Title: Jessica Sigvardson: Innovator in Antibody Research
Introduction
Jessica Sigvardson is a prominent inventor based in Spånga, Sweden. She has made significant contributions to the field of neuroscience through her innovative research on antibodies. With a total of 2 patents, her work focuses on addressing critical health issues, particularly those related to neurodegenerative diseases.
Latest Patents
Jessica's latest patents include groundbreaking discoveries in antibody technology. One of her notable inventions is the α-synuclein protofibril-binding antibodies. This invention is based on the discovery of antibodies that selectively target human α-synuclein aggregates, such as oligomers and protofibrils, specifically BAN0805. This antibody demonstrates a lower tendency to bind to the undesired monomeric α-synuclein target compared to the mouse monoclonal antibody mAb47. Another significant patent involves Aβ protofibril-binding antibodies, which relate to the amyloid beta peptide (Aβ). This invention focuses on antibodies that bind to Aβ protofibrils and their potential use in the therapy and prophylactic treatment of Alzheimer's disease and other disorders associated with Aβ protein aggregation. Additionally, this invention may aid in the diagnosis of such diseases and monitoring disease progression.
Career Highlights
Throughout her career, Jessica has worked with notable companies in the field of neuroscience. She has been associated with Bioarctic Neuroscience AB and Eisai R&D Management Co., Ltd. These experiences have allowed her to collaborate with leading experts and contribute to significant advancements in her field.
Collaborations
Jessica has collaborated with talented individuals such as Charlotte Nerelius and Hanna Laudon. These partnerships have further enriched her research and innovation efforts.
Conclusion
Jessica Sigvardson is a remarkable inventor whose work in antibody research is paving the way for new therapeutic approaches to neurodegenerative diseases. Her contributions are vital in the ongoing fight against conditions like Alzheimer's disease.